Visual vertigo analogue scale: An assessment questionnaire for visual vertigo

Dannenbaum, Elizabeth; Chilingaryan, Gevorg; Fung, Joyce

doi:10.3233/ves-2011-0412

Cited by 105 publications

(66 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Participants were contacted by telephone and administered a motion sensitivity questionnaire (MSQ) based on a visual analogue scale developed by Dannenbaum that queried motion sensitivity in several situations (Table I). 21 Questions were asked in the following way: "Do you get motion sick from (specific situation)?" Scores were defined as 0 being "no"; 1 was "somewhat"; 2 was "a lot"; and 3 was "so much so that the activity is avoided."…”

Section: Methodsmentioning

confidence: 99%

Motion sensitivity and caloric responsiveness in vestibular migraine and Meniere's disease

Sharon

Hullar

2014

The Laryngoscope

View full text Add to dashboard Cite

Objectives We examined whether scores on a motion sensitivity questionnaire (MSQ) could distinguish between vestibular migraine (VM) and Meniere's disease (MD). As a secondary goal, we examined whether scores on the MSQ correlated with results from caloric testing. Study Design This study administered a telephone questionnaire to subjects who met clinical criteria for vestibular migraine, Meniere's disease, and controls. Methods A MSQ was administered to 20 subjects meeting American Academy of Otolaryngology (AAO) criteria for MD, 30 subjects meeting Neuhauser criteria for both probable vestibular migraine (pVM) and definite vestibular migraine (dVM), and 22 controls. Results The average score on the MSQ was 5.9 for VM, 4.25 for MD, and 0.4 for controls. Both VM and MD scored significantly higher than controls (p= 0.0001), but results were not statistically different from each other (p= 0.17). However, average score for subjects with dVM was 7.1, which was significantly higher than subjects with pVM, whose average score was 4.2 (p= 0.045), and higher than subjects with MD (p=0.048). When each question of the MSQ was analyzed, motion sensitivity to riding in a car was found to be significantly different between VM (average score 1.1) and MD (average score 0.5), with p value of 0.048. Scores of MSQ did not correlate with total eye speed on caloric testing. Conclusions Subjects with VM and MD had elevated levels of motion sensitivity compared to controls. Subjects with VM had more motion sensitivity to riding in a car than those with MD, but their TES were not different.

show abstract

Section: Methodsmentioning

confidence: 99%

Motion sensitivity and caloric responsiveness in vestibular migraine and Meniere's disease

Sharon

Hullar

2014

The Laryngoscope

View full text Add to dashboard Cite

show abstract

“…The VVAS is a 9-item questionnaire that asks respondents to rate on a scale from 0-10 the amount of dizziness they experience in situations that are known triggers for patients with PPPD. 24 These include walking down a supermarket aisle, walking across a patterned floor, and going to the cinema. The item scores are then averaged, and this score is multiplied by 10.…”

Section: Visual Vertigo Analogue Scalementioning

confidence: 99%

“…The maximum score is 100. It has previously been validated on a group of patients with vestibulopathy 24 with a comparison group of people receiving outpatient orthopedic physiotherapy, but is currently untested in a general population sample.…”

Section: Visual Vertigo Analogue Scalementioning

confidence: 99%

“…To test whether PPPD symptoms exist as a spectrum in the general population, over 2,000 people completed the Visual Vertigo Analogue Scale (VVAS) 24 and the Situational Characteristics Questionnaire (SCQ), 25 2 questionnaires designed to categorize patient symptoms in clinics. We then compared the responses from the general population with those of patients diagnosed with PPPD.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Persistent postural perceptual dizziness is on a spectrum in the general population

et al. 2020

View full text Add to dashboard Cite

ObjectiveTo examine the idea that symptoms of persistent postural perceptual dizziness (PPPD) are more common than previously assumed and lie on a spectrum in the general population, thus challenging current theories that PPPD is only a consequence of a vestibular insult.MethodsWe collected 2 common clinical questionnaires of PPPD (Visual Vertigo Analogue Scale [VVAS] and Situational Characteristics Questionnaire [SCQ]) in 4 cohorts: community research volunteers (n = 1941 for VVAS, n = 1,474 for SCQ); paid online participants (n = 190 for VVAS, n = 125 for SCQ); students (n = 204, VVAS only); and patients diagnosed with PPPD (n = 25).ResultsWe found that around 9%, 4%, and 11%, respectively, of the 3 nonclinical cohorts scored above the 25th percentile patient score on 1 PPPD measure (VVAS) and 49% and 54% scored above the 25th percentile patient score on the other measure (SCQ). Scores correlated negatively with age (counter to expectation). As expected, scores correlated with migraine in 2 populations, but this only explained a small part of the variance, suggesting that migraine is not the major factor underlying the spectrum of PPPD symptoms in the general population.ConclusionWe found high levels of PPPD symptoms in nonclinical populations, suggesting that PPPD is a spectrum that preexists in the population, rather than only being a consequence of vestibular insult. Atypical visuo-vestibular processing predisposes some individuals to visually induced dizziness, which is then exacerbated should vestibular insult (or more generalized insult) occur.

show abstract

“…VAS ranking has two ranges: 0 equals to no vertigo, and 10 means the worst possible vertigo [12]. Effectiveness of each drug was assessed by VAS changes.…”

Section: Methodsmentioning

confidence: 99%

A Comparison of the Effects and Side Effects of Oral Betahistine with Injectable Promethazine in the Treatment of Acute Peripheral Vertigo in Emergency

Motamed¹,

Moezzi²,

Rooyfard³

et al. 2017

J Clin Med Res

View full text Add to dashboard Cite

BackgroundVertigo is an illusion of rotation that is caused by the asymmetry of neurological function of the right and left vestibular nuclei. The aim of this study was to compare the efficacy and side effects of oral betahistine with injectable promethazine in treatment of acute peripheral vertigo.MethodsIn this double-blind clinical trial study, the patients with acute peripheral vertigo were assigned in the two groups: receiving promethazine intramuscularly at a dose of 25 mg (group A) and receiving 8 mg betahistine tablets (group B) and the severity of their vertigo was evaluated on the visual analog scale (VAS) scoring system. In addition, adverse events in both groups of patients were compared and evaluated.ResultsA total of 162 patients (82 subjects in group A) participated in this study. The mean age, gender distribution, intensity and symptoms of vertigo were similar in both groups before the intervention. At 2 and 3 h after the intervention, the score of VAS in patients taking betahistine was significantly higher than promethazine. In addition, the clinical symptoms after taking betahistine were significantly less. Side effects seen in patients taking the promethazine include mainly drowsiness. After taking betahistine, the most common complication was abdominal problems (nausea and vomiting).ConclusionThe results of this study show that betahistine is a safe and effective drug in controlling patients with acute vertigo and its impact is more than promethazine.

show abstract

Visual vertigo analogue scale: An assessment questionnaire for visual vertigo

Cited by 105 publications

References 0 publications

Motion sensitivity and caloric responsiveness in vestibular migraine and Meniere's disease

Motion sensitivity and caloric responsiveness in vestibular migraine and Meniere's disease

Persistent postural perceptual dizziness is on a spectrum in the general population

A Comparison of the Effects and Side Effects of Oral Betahistine with Injectable Promethazine in the Treatment of Acute Peripheral Vertigo in Emergency

Contact Info

Product

Resources

About